Nalaganje...
Potentiating cancer vaccine efficacy in liver cancer
Hepatocellular carcinoma (HCC) is the most common liver malignancy with a poor prognosis and an overall 5-year survival rate of approximately 5–6%. This is due because standard of care treatment options are limited and none of them shows a sufficient efficacy. HCC is an “inflammation-induced cancer”...
Shranjeno v:
| izdano v: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6169594/ https://ncbi.nlm.nih.gov/pubmed/30288355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1488564 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|